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Abstract
 
Mast cell degranulation and de novo cytokine production is a consequence of antigen-aggrega-
tion of the immunoglobulin E (IgE)-occupied high affinity receptor for IgE (Fc
 
 
 
RI). Herein,
we report that lymphokines that promote allergic inflammation, like MCP-1, were potently
induced at low antigen (Ag) concentrations or at low receptor occupancy with IgE whereas
some that down-regulate this response, like interleukin (IL)-10, required high receptor occu-
pancy. Weak stimulation of mast cells caused minimal degranulation whereas a half-maximal
secretory response was observed for chemokines and, with the exception of TNF-
 
 
 
, a weaker
cytokine secretory response was observed. The medium from weakly stimulated mast cells elic-
ited a monocyte/macrophage chemotactic response similar to that observed at high receptor
occupancy. Weak stimulation also favored the phosphorylation of Gab2 and p38MAPK, while
LAT and ERK2 phosphorylation was induced by a stronger stimulus. Gab2-deficient mast cells
were severely impaired in chemokine mRNA induction whereas LAT-deficient mast cells
showed a more pronounced defect in cytokines. These findings demonstrate that perturbation
of small numbers of IgE receptors on mast cells favors certain signals that contribute to a
lymphokine response that can mediate allergic inflammation.
Key words: cytokines • Gab2 • IgE • LAT • mast cells
 
Introduction
 
Mast cells function in innate and acquired immunity (1, 2)
and likely through evolutionary adaptation have acquired a
role in the allergies (3). These cells perform their physio-
logical role by responding to a diverse array of challenges
through various receptors expressed on their surface and by
releasing a variety of compounds that enhance an immune
response. Central to allergic disease is the expression of the
high affinity Fc receptor for IgE (Fc
 
 
 
RI) on mast cells (4).
This receptor becomes occupied by allergen-specific IgE
primarily produced in response to T cell-dependent activa-
tion of B cells. Aggregation of IgE-occupied Fc
 
 
 
RI by a
specific allergen causes the production of mRNA or pro-
tein of IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12,
IL-13, TNF-
 
 
 
, TGF-
 
 
 
, GM-CSF, IFN-
 
 
 
, monocyte
 
chemoattractant protein 1 (MCP-1),
 
*
 
 macrophage inflamma-
tory protein 1
 
 
 
 (MIP1
 
 
 
), MIP1
 
 
 
, TCA3, LIF, ET-1,
MARC, and others (5, 6).
 
Address correspondence to Juan Rivera, NIAMS/NIH, Building 10,
Room 9N228, Bethesda, MD 20892-1820. Phone: 301-496-7592; Fax:
301-480-1580; E-mail: juan_rivera@nih.gov
 
*
 
Abbreviations used in this paper:
 
 BMMC, bone marrow–derived mast cell;
MCP-1, monocyte chemoattractant protein 1; MIP1
 
 
 
, macrophage in-
flammatory protein 1
 
 
 
; RPA, ribonuclease protection assay.T
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Receptor Occupancy Determines Generation of Signals and Responses
 
Heterogeneity in cytokines produced by different mast
cell populations is a well-documented phenomenon. Puri-
fied mouse serosal mast cells were shown to produce IL-3,
IL-6, TGF-
 
 
 
1, and TNF-
 
 
 
 (7–9) but a similar population
of rat mast cells produced only IL-6 and TNF-
 
 
 
 (10, 11).
These differences in the profile of produced cytokines can
also be seen in vitro by modifying culture conditions. For
example, addition of stem cell factor (c-KIT ligand) to a
bone marrow–derived mast cell (BMMC) causes selective
expression of IL-12 but not IL-4. In contrast, BMMC cul-
tivated in the presence of only IL-3 were reported to con-
tain mRNA for IL-4 but not for IL-12 (12). This heteroge-
neity of cytokine gene expression seemingly extends to
human tryptase
 
  
 
chymase
 
 
 
 mast cells (MC
 
T
 
) and
tryptase
 
  
 
chymase
 
  
 
mast cells (MC
 
TC
 
) as IL-5 and IL-6
were restricted to MC
 
T
 
 from allergic rhinitis patients
whereas MC
 
TC
 
 preferentially expressed IL-4 and minimal
IL-5 or IL-6 (13, 14). Furthermore, whereas 90% of puri-
fied human foreskin mast cells are positive for IL-4, only a
small number of these cells showed immunoreactivity for
IL-5 and IL-6 (14).
This plasticity in mast cell phenotype makes the mast cell
a particularly useful effector cell, capable of responding ap-
propriately to changes in its microenvironment, in both in-
nate and acquired immunity (1, 2). However, this charac-
teristic also makes it difficult to gain an understanding of the
molecular mechanisms governing a mast cells lymphokine
response to a given stimulus, as generalization of the obser-
vations is not possible given that the influence of the mi-
croenvironment may not be known. In the current study
we sought to address whether an environmentally homoge-
neous population of mast cells can differentially express cy-
tokine and/or chemokine genes as a result of an IgE-medi-
ated challenge. Specifically, we sought to answer whether
differences in the Ag concentrations or the extent of Fc
 
 
 
RI
occupancy with antigen-specific IgE could cause differences
in mast cell responses. The present study shows that mast
cells’ chemokine and cytokine responses, to a given Ag, can
differ depending on the antigen concentration or occupancy
of Fc
 
 
 
RI. This reveals a new regulatory mechanism where a
weak mast cell stimulus elicits a Th2-like lymphokine re-
sponse that supports allergic inflammation.
 
Materials and Methods
 
Reagents and Antibodies and Radiolabeling.
 
Dinitrophenyl (DNP)-
specific mouse IgE was produced as described previously (15).
Rabbit antibodies to ERK2, JNK1, and p38MAPK were from
Santa Cruz Biotechnology, Inc., mouse anti-phospho-ERK2,
rabbit anti-phospho-JNK, and rabbit anti-phospho-p38MAPK
were from Cell Signaling Technologies. Rabbit anti-phospho-
Akt (Ser472/473/474) was from BD Biosciences. Secondary an-
tibodies used for immunoblotting were: sheep anti–mouse IgG-
horseradish peroxidase (HRP) and donkey anti–rabbit IgG-HRP
(Amersham Biosciences). DNP-human serum albumin (DNP-
HSA, Ag), monovalent hapten DNP-lysine (Hap), murine
thrombin, and ATP were from Sigma-Aldrich. The MEK1 in-
hibitor, PD 98059, and the p38MAPK inhibitor, SB202190,
were from Calbiochem. Iodination of IgE was as described
 
(16) with the exception that an Iodo-Gen precoated tube
(Pierce Chemical Co.) was used. The concentration and bind-
ability of the iodinated IgE was determined as described previ-
ously (16).
 
Bone Marrow Isolation and BMMC Culture.
 
Animals were
maintained and used in accordance with National Institutes of
Health (NIH) guidelines. Bone marrow was isolated from 8-wk-
old SV129 
 
 
 
 C57/bl6 wild-type and gene-disrupted mice as de-
scribed (17, 18). LAT-null mice were kindly provided by L.E.
Samelson (NCI, NIH). Cell responses of the genetically-altered
mice were compared with age and sex matched wild type litter
mates. BMMCs were grown in RPMI media supplemented with
FBS and IL-3 as described (17, 18). Because IL-3 induces cyto-
kine mRNA responses, cells were removed from IL-3 for 4 h be-
fore stimulation.
 
Receptor Occupancy and Hapten Experiments.
 
BMMCs (1 
 
 
 
10
 
6
 
 cells/ml) were incubated in IL-3 free media containing 0.5
 
 
 
g of IgE/ml (sensitization) during 4 h at 37
 
 
 
C; conditions that
result in 100% receptor occupancy. To achieve varying degrees
of receptor occupancy the iodinated-DNP-specific mouse IgE
was mixed at varying ratios with unlabeled rat IgE of unknown
specificity. The degree of Fc
 
 
 
RI occupancy with DNP-specific
IgE was determined by direct calculation of the cell surface
bound [
 
125
 
I]-DNP–specific IgE after removal of the unbound io-
dinated-IgE by centrifugation through phtalate oils as described
(19). The remaining cells were washed twice by centrifugation
(300 
 
g
 
, 10 min) to remove the unbound IgE, stimulated with Ag
as described below and the extent of degranulation, cytokine
mRNA levels and protein secretion, and MAP kinase activation
was determined.
To analyze the effect of hapten on cytokine and chemokine
mRNA expression, BMMCs were sensitized as above with satu-
rating amounts of unlabeled DNP-specific IgE and washed twice
in Tyrodes/BSA (10 mM HEPES, 130 mM NaCl, 5 mM KCl,
1.4 mM CaCl2, 1 mM MgCl2, and 5.6 mM glucose containing
0.05% BSA) at 37
 
 
 
C. Cells were resuspended in the same buffer
at 2 
 
 
 
 10
 
6
 
/ml and three aliquots (1 ml) were transferred to tubes
containing: (a) 20 
 
 
 
l Tyrodes/BSA, or (b) 20 
 
 
 
l of Hap (2.5
mM) or (c) 20 
 
 
 
l of Hap (2.5 mM) 
 
 
 
 30 ng Ag and incubated at
37
 
 
 
C. The remaining cells were also stimulated with 30 ng/ml of
Ag at 37
 
 
 
C and 1 ml aliquots were placed in three tubes (one at
37
 
 
 
C, one on ice, and other at 37
 
 
 
C with 10 
 
 
 
l of Hap, 5 mM) at
the indicated times. Incubation continued for 60 min and hex-
osaminidase release was then determined. Cell pellets were used
for total RNA isolation.
 
Lysates, Immunoblots, Akt, MAP Kinase Analysis.
 
For prepa-
ration of cell lysates, IgE-sensitized BMMC (7 
 
 
 
 10
 
6
 
) were stim-
ulated for various times or with different concentrations of Ag in
a final volume of 250 
 
 
 
l. The reaction was stopped by the addi-
tion of 250 
 
 
 
l of boiling SDS sample buffer. For MAP kinase ex-
periments using hapten competition, 100 ng/ml of DNP-HSA
was added at t 
 
  
 
0, hapten (50 
 
 
 
M final) was added at the indi-
cated times and incubated for 10 min at 37
 
 
 
C before stopping
the reaction with SDS sample buffer. Immunoblotting condi-
tions were previously described (20, 21). Akt or MAP kinase
phosphorylation was determined by phosphospecific antibodies.
Relative quantitation of immunoblots was performed by densi-
tometry. To determine the effect of MAP kinase inhibitors,
PD98058 (10 
 
 
 
M, MEK1 and thus ERK2 selective) or
SB202190 (5 
 
 
 
M, p38MAPK selective) was added to 5 
 
 
 
 10
 
6
 
cells/ml for 15 min at 37
 
 
 
C before Ag stimulation (100 ng/ml)
for 1 h at 37
 
 
 
C. Cells were centrifuged and the pellet was used to
isolate total RNA.T
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Hexosaminidase, Chemotaxis, and Cytokine Assays.
 
Degranula-
tion was measured by assaying 
 
 
 
-hexosaminidase release as de-
scribed (18). To measure chemotaxis, mast cells were loaded with
different amounts of [
 
125
 
I]odinated-DNP-specific IgE as de-
scribed above. Thirty million cells were resuspended in 1 ml of
Tyrodes/BSA buffer at 37
 
 
 
C and stimulated with Ag (100 ng/ml)
or with an equal volume of buffer for controls. Cells were centri-
fuged and supernatants collected after 1, 2, or 4 h of stimulation.
Chemotaxis was measured by Boyden’s blind well chamber tech-
nique using 48-well microchambers (Neuroprobe) essentially as
described (22). The number of cells migrating through the filter
was determined microscopically. To measure lymphokine secre-
tion, BMMCs (5.0 
 
 
 
 10
 
7
 
 cells) were incubated with IgE as de-
scribed above to achieve known receptor occupancies. Cells were
stimulated with Ag (10 or 100 ng/ml) at 37
 
 
 
C for varying times
(1–24 h) and centrifuged at 4
 
 
 
C for collection of the supernatant.
Lymphokine concentration was determined by ELISA (Bio-
source International) as previously described (23).
 
RNA Extraction, RT-PCR, and Ribonuclease Protection Assay.
 
Pellets from stimulated cells (2 
 
 
 
 10
 
6
 
 per sample) were solubi-
lized in 1 ml of TRI-Reagent (Molecular Research Center) for
15 min at room temperature. Low abundance mRNA was mea-
sured by RT-PCR. First strand cDNA synthesis was with the
Life Technologies SuperScript first-strand synthesis system. Prim-
ers for amplification of IL-2, IL-3, IL-4, IL-10, and IFN-
 
 
 
 were
obtained from CLONTECH Laboratories, Inc., and PCR condi-
tions were: 96
 
 
 
C for 1 min; 2 cycles of 96
 
 
 
C for 1 min and 60
 
 
 
C
for 4 min; 28 cycles (IL-4) or 35 cycles (IL-2, IL-3, IL-10, IFN-
 
 
 
)
of 94
 
 
 
C for 1 min, 60
 
 
 
C for 2.5 min, and 72
 
 
 
C for 4 min, addi-
tional extension at 72
 
 
 
C for 10 min; and holding at 4
 
 
 
C. Cyto-
kine mRNA detection was linear. Fragments were separated on
2% TBE-agarose gels and a negative exposure was used for densi-
tometric quantitation.
For ribonuclease protection assay (RPA), either commercially
available multiprobe template sets or two custom-made templates
were used (BD Biosciences). Cytokine genes included were
TNF-
 
 
 
, IL-13, M-CSF, LIF, and IL-6. Chemokine genes were
MIP1
 
 
 
, MIP1
 
 
 
, MIP-2, LIF, and MCP-1. L32 and GAPDH
were control genes. Probe synthesis was with RiboQuant™ In
vitro Transcription Kit (BD Biosciences) and 100 
 
 
 
Ci of [
 
 
 
-
 
33
 
P]-
UTP (ICN Biomedicals), following the provided protocol. Hy-
bridization used 10 
 
 
 
g of total RNA and 10
 
6
 
 cpm of probe in 13
 
 
 
l of hybridization buffer at 56
 
 
 
C overnight. RNaseI digestion
and subsequent steps were per manufacturer’s instruction. Precip-
itation of protected fragments was in the presence of 1.5 
 
 
 
g of
carrier, glycoblue (Ambion). Fragment resolution was on a dena-
turing 6% polyacrylamide gel, which was autoradiographed and
developed in Kodak Biomax Transcreen-LE using Kodak
BioMax MS (Eastman Kodak Co.) film. Quantitation of the au-
toradiograph was by densitometry using ImageQuant
 
®
 
 software
version 3.3 from Molecular Dynamics. Data was normalized to
the control genes L32 or GAPDH.
 
Results
 
Mast Cell Cytokine mRNA Profiles Are Similar in Response
to Different Stimuli.
 
We initially tested the hypothesis that
differential expression of mast cell cytokine mRNA could
occur as a consequence of the stimulus used to activate the
cell. Cells were stimulated with IgE/Ag, thrombin, and
ATP as the receptors (Fc
 
 
 
RI, proteinase-activated recep-
tor-1 (PAR-1), and purinergic receptors, respectively) re-
sponding to each stimulus utilize a different functional cou-
pling mechanism; namely, nonreceptor tyrosine kinases
(24), the G
 
i
 
 subclass (25), and the G
 
q
 
 subclass (26) of het-
erotrimeric GTP binding proteins, respectively. As shown
in Fig. 1, all three stimuli were capable of inducing degran-
ulation. Additionally, all three stimuli induced the same cy-
tokine mRNA profile (Table I). However, ATP showed a
tendency to induce a stronger degranulation and cytokine
response than IgE/Ag whereas thrombin was only able to
induce between 20 to 33% of the IgE/Ag or ATP re-
Figure 1. Mast cell degranulation is dif-
ferentially induced by IgE/Ag, thrombin,
and ATP. BMMCs were stimulated with
the indicated concentrations of Ag, throm-
bin, or ATP for 60 min at 37 C. Hex-
osamindase release was measured as described
(reference 18) and reported as the percent of
the total cellular amount. Data is the average
of four experiments with standard deviation.T
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Table I. Stimulated BMMC Lymphokine mRNA Response (% of Resting Levels   SEM)
RPA RT-PCR
Gene DNP Thrombin ATP DNP Thrombin ATP na
IL-1  ndb nd nd ntc nt nt 2, 0
IL-1  460   35 130   12 996   46 nt nt nt 2, 0
IL-1R nd nd nd nt nt nt 2, 0
IL-2 nd nd nd 1,732   120 1,400   136 2,500   219 1, 3
IL-3 nd nd nd 776   128 125   16 929   115 1, 3
IL-4 nd nd nd 1,760   217 218   74 3,280   195 1, 3
IL-5 nd nd nd nt nt nt 1, 0
IL-6 1,636   162 322   93 2,248   131 1,589   216 398   91 2,179   154 2, 2
IL-7 nd nd nd nt nt nt 1, 0
IL-9 nd nd nd nt nt nt 1, 0
IL-10 nd nd nd 738   214 198   22 917   254 2, 3
IL-11 nd nd nd nt nt nt 2, 0
IL-12 p35 nd nd nd nt nt nt 2, 0
IL-12 p40 nd nd nd nt nt nt 2, 0
IL-13 1,239   265 150   23 2,569   194 nt nt nt 3, 0
IL-15 nd nd nd nt nt nt 2, 0
IL-18 nd nd nd nt nt nt 2, 0
IFN-  nd nd nd 750   136 182   16 1,200   176 2, 3
IFN-  nd nd nd nt nt nt 2, 0
MIF 120   29 100   23 435   49 nt nt nt 3, 0
TNF  1,065   168 220   31 2,225   241 987   165 200   29 2,161   264 3, 3
TNF  nd nd nd nt nt nt 2, 0
Ltb nd nd nd nt nt nt 2, 0
TGF 1 n dn dn d n t n t n t 2 ,  0
TGF 2 350   106 114   8 810   103 nt nt nt 2, 0
TGF 3 n dn dn d n t n t n t 2 ,  0
GM-CSF nd nd nd nt nt nt 2, 0
M-CSF 720   109 670   83 1,150   179 nt nt nt 3, 0
G-CSF nd nd nd nt nt nt 2, 0
LIF 1,118   206 207   28 1,886   103 nt nt nt 3, 0
SCF nd nd nd nt nt nt 2, 0
Ltn nd nd nd nt nt nt 2, 0
Rantes nd nd nd nt nt nt 2, 0
Eotaxin nd nd nd tn nt nt 2, 0
MIP-1  906   218 563   149 1,578   189 nt nt nt 3, 0
MIP-1  1,724   297 869   201 2,100   297 nt nt nt 3, 0
MIP-2 724   297 382   71 1,079   128 nt nt nt 3, 0
MCP-1 1,245   183 796   108 1,689   219 1,197   172 975   171 1,956   347 3, 3
TCA-3 nd nd nd nt nt nt 2, 0
L32 100 100 100 nt nt nt 3, 0
GAPDH 100 100 100 100 100 100 3, 3
BMMCs were loaded with DNP-specific IgE in media without IL-3 for approximately 4 h. After washing with Tyrodes/BSA, cells were stimulated
with different concentrations of DNP, thrombin, or ATP and degranulation (hexosaminidase release) was determined as described in Materials and
Methods. Pellets were used for total RNA extraction and RPA or RT-PCR was performed. Data in the table is the maximal response obtained for
each gene after 1 h of stimulation with each agent under conditions where accumulation of the mRNA was linear.
an, the number of experiments done; RPA, RT-PCR.  
bnd, not detected.
cnt, not tested.T
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sponses. Notable exceptions were found in IL-2 and the
chemokines, MIP-1 , MIP-1 , M-CSF, and MCP-1,
where thrombin stimulation elicited  50% of the response
obtained with IgE/Ag. These initial experiments provided
evidence of the potential for mast cells to express similar
cytokine profiles to diverse stimuli, but also suggested that
differential sensitivity of certain genes to a stimulus could
influence the cytokine profile.
Selective IgE-mediated Induction of Mast Cell Cytokine
mRNA Occurs in Response to Varying Concentrations of Ag.
To test whether the strength of a stimulus affected the cy-
tokine mRNA profile we focused solely on IgE/Ag-medi-
ated responses because this system was readily amenable to
manipulation of the number of receptor aggregates by
varying the concentration of Ag or the amount of IgE-
occupied Fc RI. As shown in Fig. 2 A, synthesis of IFN- ,
TNF- , IL-2, IL-3, IL-4, IL-6, IL-10, IL-13, M-CSF, LIF,
MIP-1 , MIP-1 , MIP-2, and MCP-1 was detected by
RPA or by RT-PCR. Quantitation of the net response to
varying concentrations of Ag revealed that the mRNA
acummulation of MIP-1 , MIP-1 , MCP-1, M-CSF, IL-2,
and IL-4 reached a maximum at significantly lower con-
centrations of Ag than IL-3, IL-6, IL-10, LIF, MIP-2,
TNF- , and IFN-  (Fig. 2, B and C). Quantitative analysis
of the effective concentration of Ag required for 50% of
the maximal response (EC50), summarized in Table II,
showed that genes, like MIP-1  and  , were extremely
sensitive to small amounts of Ag whereas others, like IL-3
and IL-10, required almost 10-fold higher concentrations
to reach their EC50. Interestingly, some chemokine and cy-
tokine mRNA responses reached their EC50 at concentra-
tions of Ag that elicited minimal degranulation (Fig. 1).
This suggested that aggregation of small numbers of recep-
tors was sufficient to induce increased mRNA levels of
most tested chemokines and some cytokines in the absence
of substantial degranulation.
The Level of Receptor Occupancy with IgE/Ag Causes Differ-
ential Expression of Cytokines and Chemokines. It has been
suggested that atopic individuals may differ in their symp-
toms because the amounts of allergen-specific IgE pro-
duced, and thus receptor occupancy, may differ (27, 28).
To test this hypothesis cells were loaded with [125I]-labeled
Figure 2. The antigen concentration determines the profile of lymphokine mRNA induced in activated BMMCs. IgE–sensitized cells were stimulated
with different amounts (ng/ml) of DNP-HSA (Ag). Hexosaminidase release was determined (Fig. 1). Total RNA was extracted for RPA and RT-PCR.
(A) A representative RPA and RT-PCR experiment showing the Ag concentration-dependent response of the indicated lymphokines and the controls
L32 and GAPDH. (B and C) Densitometric quantitation of the increase in mRNA response to varying concentrations of Ag (as a percent of the maximal
response observed). The shown curves are representative of the response observed for each apparent group. IFN-  did not fit in any group. Data shown
is the mean of at least three individual experiments for each lymphokine with standard errors.T
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DNP-specific mouse IgE at varying ratios in order to ob-
tain a known occupancy of receptors. Fig. 3 A shows that
degranulation is relatively linear with increasing receptor
occupancy, thus, half maximal degranulation is reached
when  50% of the receptors are occupied. In contrast,
 50% of the maximal mRNA accumulation for MCP-1,
M-CSF, and IL-4 was observed with  10% of the recep-
tors occupied by IgE/Ag (Fig. 3, B and C). 50% of the
maximal mRNA response for MIP-1 , MIP-1 , and
MIP-2, required between 30–40% IgE receptor occu-
pancy. IL-2, IL-6, IL-13, TNF- , and LIF required
greater than 40% IgE receptor occupancy and IL-10
showed a half-maximal response only when receptor occu-
pancy was greater than 60%.
We tested if extracellular secretion of lymphokines could
occur under conditions of low receptor occupancy. For
most lymphokines, 5 h of stimulation was sufficient to
reach maximal secretion. When 10% of Fc RI was occu-
pied by IgE/Ag MCP-1 was potently secreted, with 2076.5
pg/106cells detected in the medium (Table III). This repre-
sented  42.9% of the secretion observed at 100% occu-
pancy. IL-6, MIP-1 , MIP-1 , and TNF-  were also se-
creted at amounts that were 10.9%, 48.8%, 48.0%, and
34.1% of the maximal secretion, respectively (Table III).
The secreted lymphokines induced a potent monocyte/
macrophage (J774.1 cells) chemotactic response that was
similar to that observed at full receptor occupancy (Fig. 3
D). MCP-1 alone, at concentrations similar to those se-
creted (1,000–4,000 pg/106  cells), caused a comparable
chemotatic response. IL-4 and IL-10 were not detected at
5 h after stimulation but small amounts were detected after
24 h of stimulation. Under low receptor occupancy only
IL-4 was detected whereas IL-10 was not (Table III).
Quantitation of secreted IL-6 and secreted MCP-1 showed
that at low receptor occupancy almost a 10-fold difference
in absolute amounts of these lymphokines exists whereas
this difference is strikingly narrowed (2.3-fold) at high re-
ceptor occupancy. With the exception of TNF- , the re-
sults are consistent with a skewed lymphokine response that
favors chemokines at low receptor occupancy. Fc RI-
mediated TNF-  mRNA responses required higher Ag
concentrations or receptor occupancy (Figs. 2 and 3), how-
ever, substantial secretion of TNF- , upon a weak
stimulus, may result as a consequence of its synthesis and
storage in preformed secretory granules (8).
IgE/Ag-induced Gene Responses Show Dependence or Early
Independence of Receptor Aggregation. We previously dem-
onstrated that TNF- , which requires high receptor oc-
cupancy for complete induction, was exquisitely sensitive
to disaggregation of receptors by a monovalent hapten
(29). We reasoned that it was possible that genes that re-
quired a larger number of receptor aggregates could be
most sensitive to disruption of receptor aggregates and
vice versa. As shown in Fig. 4 A, degranulation of mast
cells required continued aggregation of receptors for up to
6 min after Ag addition. At 3 min after Ag addition, hap-
ten addition resulted in  50% of the normal degranula-
tion response. The inhibitory effect of hapten was mir-
rored by the addition of ice cold buffer indicating the
interruption of an active process.
Analysis of the sensitivity of the cytokine and chemokine
mRNA response to hapten revealed three distinct re-
sponses: first, mRNA accumulation of MIP-1 , MIP-1 ,
MCP-1, and M-CSF became rapidly independent (be-
tween 1–4 min after Ag stimulation) of continued receptor
aggregation (Fig. 4 B). Second, mRNA accumulation of
LIF, IL-3, IL-4, IL-6, and IL-10 became independent of
continued receptor aggregation between 4 and 8 min after
Ag stimulation (Fig. 4 C). Third, mRNA accumulation of
IL-2, IL-13, IFN- , and TNF-  required more than 15
min to show considerable independence of receptor aggre-
gation (Fig. 4 D). Non-linear regression analysis of the
mRNA response of IL-2, IL-13, IFN- , and TNF- 
showed two distinct groups (IL-2, IFN-  and IL-13, TNF-
 ). However, the cytokines in each group showed a poor
fit suggesting additional regulatory complexity in their re-
sponse. With some notable exceptions, like IL-2, most
mRNA responses induced at low Ag concentrations or low
receptor occupancy became rapidly independent of contin-
ued receptor aggregation. Vice versa, those genes requiring
high Ag concentrations or high receptor occupancy for in-
duction were more dependent on continued receptor ag-
gregation. Despite the noted exception, this suggests that
most genes the respond to low Ag or low receptor occu-
pancy conditions can generate intermediates that rapidly
become independent of continued receptor aggregation.
Table II. Half-maximal (EC50) Lymphokine mRNA Response of 
BMMCs to Ag
Gene Ag concentration (ng/ml)a nb
MIP-1  1.1   0.5 4
IL-4 1.1   0.3 3
IL-2 1.2   0.3 3
MIP-1  1.3   0.6 4
M-CSF 1.7   0.3 5
MCP-1 1.9   0.4 4
IFN-  3.6   0.4 3
IL-13 5.4   0.3 5
TNF-  5.6   0.7 5
MIP-2 8.9   1.2 4
LIF 9.8   1.8 4
IL-6 10.4   2.7 5
IL-10 11.7   2.3 3
IL-3 14.3   2.2 3
The Ag (DNP-HSA) concentration for half-maximal response (EC50)
was calculated from the data shown in Fig. 2. Data is the mean of all
experiments with standard error. Data is arbitrarily grouped. 
aAg concentration is expressed in ng/ml and is the concentration re-
quired to see a half-maximal response (EC50). 
bn is the number of experiments done for each lymphokine and used in
calculation of the EC50.T
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Low Ag or Low Receptor Occupancy Favors Fyn/Gab2-initi-
ated Signals and Activation of p38MAPK. Fyn and Lyn ki-
nases are Fc RI-proximal Src family kinases that propagate
signals through the adapters Gab2 and LAT, respectively
(30, 31). Gab2 is required for the activation of PI3K and
Akt in mast cells whereas LAT is essential for calcium re-
sponses (30, 32). We now tested if low Ag concentrations
or low receptor occupancy could induce the phosphoryla-
tion of the adapters Gab2 or LAT and other proteins
downstream of these adapters. As shown in the upper panel
of Fig. 5 A, low Ag concentrations were substantially effec-
tive in stimulating the phosphorylation of Fyn, Gab2, and
the p85subunit of PI3K. Because the available antibodies to
Gab2 are of relatively low affinity, phosphorylated Gab2
was difficult to detect below stimulation with 1 ng/ml of
Ag. LAT phosphorylation was detected at 10 ng/ml of Ag.
Low receptor occupancy also showed a preference for the
Gab2/PI3K pathway as the downstream kinase, Akt, was
phosphorylated to  80% of that seen at high receptor oc-
cupancy (Fig. 5 A, bottom panel). In contrast, ERK2 phos-
phorylation, which depends primarily on LAT (18), was at
best 15% of that seen at high receptor occupancy when
films were overexposed. This suggested that the Gab2/
PI3K pathway was more sensitive in its response to low Ag
or low receptor occupancy. Given our previous finding of
a potent MCP-1 response under conditions of low Ag con-
centrations or low receptor occupancy, this suggested that
Gab2 might be more important to MCP-1 mRNA re-
sponses than LAT. As shown in Fig. 5 B, Gab2-deficient
mast cells were defective in the mRNA response of all the
Figure 3. Effect of receptor occu-
pancy on degranulation, lymphokine
mRNA production, and monocyte/
macrophage chemotaxis. (A) BMMCs
with varying receptor occupancy
(with IgE) were stimulated with Ag
(10 ng/ml) and hexosaminidase re-
lease was measured (reference 18).
Fit has a R2 value of 0.9275, with a
slope of 0.9792 to 1.256 within the
95% confidence interval. (B and C)
The RNA from the experiments
shown in panel A was analyzed by
RPA and RT-PCR. mRNA induc-
tion of cytokines and chemokines
was quantitated by densitometry and
expressed as a percent of the maxi-
mal mRNA increase for each lym-
phokine. Curves shown are repre-
sentative of the distinct mRNA
responses observed. (D) The me-
dium from Ag-stimulated BMMCs
having low (17.0%   1.5) or high
receptor occupancy (100.0%) with
IgE was collected at the indicated
times after Ag stimulation. Chemo-
taxis of the monocyte/macrophage
cell line J774.1 induced by the col-
lected medium was measured using a
Boyden chamber assay. MCP-1 (1
or 4 ng/106 cells) was added for 4 h as a positive control. Five randomly selected high power fields were counted per filter. Data shown is the net average
of two experiments with triplicate samples. Migration toward medium from unstimulated cells (41   7 cells per field) is subtracted.
Table III. BMMC Secretion of Lymphokines at Low and High 
Receptor Occupancies
Lymphokine
Time
(h)
pg/106 cells
10%
occupancya
pg/106 cells
100% 
occupancya
Percentage of
secretion at
100% 
occupancyb
MCP-1 5 2,076.5 4,837.2 42.9
IL-6 5 231.4 2,117.3 10.9
MIP-1  5 220.8 452.6 48.8
MIP-1  5 59.8 124.5 48.0
TNF-  5 52.4 153.6 34.1
IL-4* 24 2.3 4.0 57.5
IL-10* 24 ndc 15.9 –
BMMCs were stimulated with 10 or 100 ng/ml of Ag (DNP-HSA) for
the indicated time. After centrifugation the supernatant was recovered and
the amount of lymphokine secreted was measured by ELISA as described
in Materials and Methods. Data is from two independent experiments
using two different BMMC cultures. *Data is from one experiment as
detection of these cytokines was below the sensitivity of the assay in a
second experiment. Standard deviations ranged up to 18.7%. 
a% receptor occupancy was determined by counting the cell bound
cpm of the [125I]-DNP-specific IgE for each sample and dividing by the
cpm bound on cells incubated with saturating amounts of [125I]-DNP-
specific IgE. 
bPercentage of secretion at 100% occupancy was calculated by dividing
the amount of lymphokine produced (pg/106 cells) at 10% receptor
occupancy by the response observed at 100% receptor occupancy. 
cnd is not detected (below the sensitivity of the assay).T
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tested chemokines whereas cytokine mRNA responses
were less severely affected. Strikingly, LAT-deficient mast
cells showed the opposite profile with cytokines being
more severely inhibited than chemokines. In Gab2-defi-
cient mast cells, the inhibition of chemokine mRNA re-
sponses ranged from 65–90% depending on receptor occu-
pancy. Gab2 deficiency also caused a 10–30% inhibition of
cytokine mRNA responses. In contrast, LAT-deficient
mast cells showed an inhibition of chemokine mRNA re-
sponses that ranged from 15–40% with MCP-1 and LIF
mRNA responses being unaffected. Cytokine mRNA re-
sponses were more severely affected by LAT-deficiency
with inhibition ranging from 40–80%.
To gain a further understanding of the influence of re-
ceptor occupancy on gene expression we explored the ac-
tivation (phosphorylation) of MAP kinases. Fig. 6 A dem-
onstrates that p38MAPK was most sensitive to low
receptor occupancy with 50% of the maximal phosphory-
lation detected at  12% receptor occupancy. In contrast,
ERK2 required more than 25% and JNK1 more than 40%
occupancy to reach 50% of their maximal phosphorylation
levels. It should be noted that consistent with greater sen-
sitivity of Gab2 to weak stimulation, a previous report
demonstrated impaired p38MAPK activation in Gab2-
deficient mast cells (32). We postulated that if p38MAPK
activation is required for production of lymphokines that re-
spond under weak stimulation, like MCP-1, its activation
should become rapidly independent of continued receptor
aggregation (like MCP-1). Fig. 6 B shows that p38MAPK
becomes rapidly independent of continued receptor aggre-
gation (1 min). The activation of both JNK and ERK2
showed a greater dependence on continued receptor ag-
gregation with independence being achieved after 3 and 8
min post-Ag stimulation, respectively (graph, Fig. 6 B).
Together, with prior results on chemokine responses,
these findings demonstrate a relationship between sensitiv-
ity to a weak stimulus and rapid independence of contin-
ued receptor aggregation. They also provide suggestive
evidence for the importance of p38MAPK in the mRNA
responses (like MCP-1) induced by low Ag concentration
or low receptor occupancy.
MCP-1 and TNF-  Genes Show Preferential Requirement
for p38MAPK or ERK2, Respectively. While it is well un-
derstood that multiple pathways cooperate with the activ-
ity of MAP kinases in gene expression (33, 34), we tested
whether the mRNA accumulation of some cytokines and
chemokines showed preferential sensitivity to inhibition
of p38MAPK and ERK2 by SB202190 and PD98059, re-
spectively. We chose to analyze the sensitivity of two
genes that well-represent mRNA induction by low IgE/
Ag receptor occupancy (MCP-1) or high IgE/Ag receptor
occupancy (TNF- ; see Fig. 3, B and C). Fig. 7 shows
that pretreatment of BMMC with PD98059 inhibited
TNF-  mRNA accumulation by 70%, whereas SB
Figure 4. Differential require-
ment for continued IgE receptor
aggregation in lymphokine
mRNA responses and degranu-
lation. (A) IgE-sensitized cells
were stimulated with Ag (10 ng/
ml). Receptor aggregation was
stopped by addition of monova-
lent hapten (DNP-lysine) at the
indicated times. In parallel, other
samples were placed on ice to
stop Ag-stimulated degranulation
or left at 37 C for 30 min. Hex-
osaminidase release was deter-
mined. Nonlinear regression
analysis of the response to hapten
and buffer (4 C) showed a best
fit with an R2 value of 0.9311.
(B, C, and D) RNA was ex-
tracted from the cells in panel A
and RPA or RT-PCR was per-
formed. Three distinct groups of
mRNA responses were found
based on nonlinear regression
analysis. Responses that rapidly
became independent of receptor
aggregation (B), responses that
were intermediate in their re-
quirement for continued recep-
tor aggregation (C), and responses that required prolonged receptor aggregation (C). The latter group showed a poor fit (R2) in a nonlinear regression
analysis. Data shown is the mean of a minimum of three individual experiments with standard error.T
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202190 inhibited TNF-  mRNA accumulation by
 30%. In contrast, SB202190 inhibited MCP-1 mRNA
accumulation by almost 80% whereas PD98059 had no ef-
fect on the mRNA accumulation of this chemokine.
However, another analyzed gene, IL-13, which re-
sponded to intermediate Ag concentrations or receptor
occupancy, was not as effectively inhibited ( 23–38%) by
SB202190 or PD98059. The findings are consistent with
Figure 5. Low Ag concentration
or low receptor occupancy causes
preferential induction of Fyn/Gab2/
PI3K/Akt phosphorylation and
Gab2- or LAT-deficiency preferen-
tially inhibits chemokine or cytokine
mRNA responses, respectively. (A)
IgE-sensitized BMMCs were stimu-
lated for 3 min with the indicated
concentrations of Ag. Phosphopro-
teins were immunoprecipitated with
anti-phosphotyrosine (Anti-pY) and
immunoblots were probed with the
indicated antibodies. (Bottom panel)
BMMCs sensitized with IgE at 15%
or 100% receptor occupancy were
stimulated with Ag (10 ng/ml) for
the indicated time. Phosphorylation
of Akt and ERK2 was determined
with phospho-specific antibodies.
Protein levels were determined by
reprobing of immunoblots with
anti-Akt or anti-ERK2. One repre-
sentative of four experiments is
shown. Fold induction is the average
from four experiments. (B) BMMCs
from Gab2-deficient or LAT-defi-
cient mice were sensitized as in
panel A, bottom panel, to obtain the
indicated occupancy of receptors
with IgE. Cells were stimulated with
Ag (10 ng/ml) for 1 h and RNA was
extracted. One representative RPA
experiment of four for Gab2 and
two for LAT is shown. Exposure
shown is where all responses ob-
served were in the linear range of de-
tection. Overexposure showed sig-
nificant induction of chemokines at
5% occupancy for the Gab2 analysis.T
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induction of p38MAPK and ERK2 at low or high IgE/Ag
receptor occupancy as important in MCP-1 and TNF- 
mRNA responses, respectively.
Discussion
Herein, we describe that weak Fc RI stimulation of
mast cells causes preferential cell signaling and a lympho-
kine response that shows potent chemokine production.
Our findings demonstrate that a homogeneous population
of mast cells can respond differently to the same allergen
depending on its concentration or on the extent of recep-
tor occupancy (number of receptor aggregates), or the per-
sistence of the allergen (continued receptor aggregation).
Recently, there is increased awareness of the importance
of the stability or life span of a receptor in an aggregate
complex. It is thought that the life span of an activated re-
ceptor in a receptor aggregate is important for the genera-
tion of signals that lead to “productive” cellular responses
(35–38). One well studied system is the TCR, where stud-
ies demonstrate that the strength of the signal can cause dif-
ferent cellular responses. Thus, weak TCR stimulation in-
duces a calcium signal that is sufficient to trigger IL-4
synthesis whereas stronger TCR stimulation induces MAP
kinase activation that controls IFN-  production (37).
Other studies show that the pattern of signaling events in-
duced by stimulation of the TCR with low doses of pep-
tides, by a partial agonists, or by CD28 costimulation can
cause differential responses or anergy (39–41), and even de-
termine Th1 or Th2 differentiation (42). Physiological
concentrations of the B7 ligand, that stimulates CD28 on T
cells, causes preferential activation of a subset of the signal-
ing molecules observed when T cells are activated by anti-
body to CD3 or by antibody costimulation of the TCR
and CD28 (42, 43). Hence, the view arising from these
studies is that the overall potency of the stimulus is critical
in determining what signals are generated and what cellular
outcomes are observed.
T.W. McKeithan introduced a “kinetic proofreading”
model to explain the ability of the TCR to discriminate
between different ligands that might bind the same recep-
tor but elicit different cellular outcomes (44). Central to
this tenet is that the initiating ligand–receptor interaction
be maintained for sufficient time to allow the occurrence of
the required series of events leading to a particular cellular
response. Torigoe and colleagues demonstrated that the
Figure 6. Sensitivity of MAP kinase activation to receptor occupancy
and continued receptor aggregation. (A) BMMC were sensitized at vary-
ing densities of receptor occupancy with IgE and stimulated with Ag (100
ng/ml) for 10 min. Phosphorylation of p38MAPK, JNK1, and ERK2 was
measured using phosphospecific antibodies. Quantitation of phosphoryla-
tion was by densitometry and is expressed as a percent of the maximal
phosphorylation observed at 100% receptor occupancy. Data is from two
individual experiments. (B) BMMCs were sensitized with IgE at 100%
receptor occupancy and stimulated as in panel A. The monovalent hapten
(DNP-lysine) was added at the indicated times after Ag stimulation. Phos-
phorylation of p38MAPK, JNK1, and ERK2 was measured using phos-
phospecific antibodies. One representative experiment is shown. Graph
shows the average of densitometric quantitation of three experiments ex-
pressed as % inhibition of the response in absence of hapten.
Figure 7. Treatment of BMMCs with the MAP kinase inhibitors,
SB202190 and PD98058, shows the preferential requirement of
p38MAPK and ERK2 for induction of MCP-1 and TNF- , respectively.
IgE-sensitized BMMCs were preincubated for 15 min at 37 C with 5
 M of the p38 MAPK inhibitor SB202190 or 10  M of the ERK2 up-
stream kinase, MEK1, inhibitor PD98058. Control cells were preincu-
bated in the absence of inhibitors. Cells were activated or not with Ag
(100 ng/ml) and RNA was extracted and RPA was performed. Quantita-
tion of RPA films was by densitometry and is expressed as a percent of
the maximal response observed in the absence of inhibitors.T
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Fc RI is also under the constraints of “kinetic proofread-
ing” (36). Using a low affinity ligand and conditions where
receptor phosphorylation was similar to that produced by a
high affinity ligand, the phosphorylation of the down-
stream effectors, Syk, Nck, ERK2, as well as mast cell de-
granulation was progressively diminished. This suggested
that the low affinity ligand failed to maintain an interaction
with the receptor for sufficient time to generate the re-
quired intermediate states leading to mast cell degranula-
tion (36). However, later observations showed that MCP-1
production occurred with a low affinity ligand, suggesting
that some signaling intermediates can become independent
of the kinetic proofreading requirement (45). With some
exceptions (as noted below), we found that genes induced
by low Ag or low receptor occupancy are regulated by in-
termediates that rapidly become independent of the need
for continued ligand:receptor interactions. In contrast,
genes requiring high Ag or high receptor occupancy were
more dependent on continued ligand:receptor interactions
suggesting that the generation of appropriate intermediates
required sustained interactions. It should be noted that IL-2
and IL-10 mRNA responses were an exception to this gen-
eralization. However, in T cells these genes show exquis-
itely complex transcriptional and posttranscriptional regula-
tion that may differ based on the strength or the type of
stimulus (46, 47).
The finding that some signals are more sensitive to a
weak stimulus is an important addition to our understand-
ing of Fc RI function. The stronger induction of certain
lymphokines has significant physiological implications
(discussed below). However, the findings also demonstrate
that the recently described Fyn-initiated signaling pathway
that uses the adaptor Gab2 (30, 32) is seemingly more sen-
sitive to a weak stimulus than the adaptor LAT. However,
a weak stimulus is also likely to make LAT partly func-
tional since ERK2 activation (at 15% of levels seen with a
strong stimulus) can be detected and overexposure of im-
munoblots showed a weak LAT phosphorylation (unpub-
lished data). A weak stimulus might also serve to prime the
cells signaling apparatus to a subsequent challenge, as aner-
gic T cells showed a lowered activation threshold for in-
duction of CD25 and CD69 in response to an antigenic
stimulus (48). The finding that Fc RI can differentially ac-
tivate MAP kinases, depending on stimulus strength, is
supported by studies showing the rapid induction of
p38MAPK activity in mast cells and basophils (49) and the
requirement for minimal activation of p38MAPK for in-
creased cyclooxygenase-2 expression in RBL cells (50).
Because Gab2 was shown to be upstream of p38MAPK
(32) these findings support the notion that a weak stimulus
more strongly activates signals associated with the Gab2
than those associated with LAT. Gab2 was shown (51) to
reside in membrane domains that exclude LAT but con-
tain Fc RI. Hence, preferential signaling may also reflect
the kinetics of Fc RI coupling to Gab2 as preceding the
coupling to LAT. However, it should be noted that weak
signals in the LAT pathway are apparent under a weak
stimulus and the relative contribution of LAT to produc-
tion of chemokines like MIP-1  and MIP-1  is still sig-
nificant (Fig. 5 B).
It was recently recognized that chemokines and chemo-
kine receptors play an important role in allergic airway dis-
ease (52, 53) and antichemokine therapy represents a new
and promising approach to allergy immunotherapy (54).
The expression of the chemokine MCP-1, during cutane-
ous allergic reactions, is mast cell dependent and primarily
responsible for the influx of monocytes to the reaction sites
(55). Moreover, the selective production of chemokines in
the absence of mast cell degranulation was reported in re-
sponse to Dengue virus infection (56). We now demon-
strate that conditions of low occupancy by IgE or low Ag
induces a potent production of chemokines, like MCP-1
and MIP-1 , that can recruit macrophages, monocytes,
and other leukocytes. Importantly, this occurs in the ab-
sence of considerable mast cell degranulation and of immu-
noregulatory cytokines, like IL-10, which down-regulate
the Th2 response. Our findings suggest that a weak allergen
or a small number of receptors occupied with an allergen-
specific IgE can elicit mast cell–mediated inflammation and
is consistent with the idea that production of chemokines is
central to the allergic inflammation. This defines a previ-
ously unrecognized plasticity in mast cell responses that is
likely to be an important component of a mast cells func-
tion in health and disease.
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